Clinical and Experimental Hypertension Part B Hypertension in Pregnancy · 1987 · 62 citations · 25 references
Life SciencesNeurosciencePhysiologyMaternal-fetal MedicineNeuroendocrinologyReproductive PhysiologyFetal PhysiologyHypertensive DisordersMaternal-fetal PhysiologyPregnancyPregnancy PhysiologyPregnancy-induced HypertensionGestational Hypertension PhysiologyInduced HypertensionPreeclampsia PathophysiologyPregnancy-induced Hypertension PhysiologyPregnancy-related Blood Pressure RegulationPregnancy-related Hypertension
The Sprague-Dawley laboratory rat served as an experimental model for pregnancy-induced hypertension. Generation of systemic hypertension depended upon a surgical reduction of blood pressure by 30–35% to the uteroplacental unit. Blood pressures during the final trimester of rat pregnancy typically rose from a normal of 125/80 mm Hg to 160/100 mm Hg within 4 days of surgery; they fell to normal by 5 days post partum. A 7.5-fold rise in proteinuria accompanied development of the hypertension. Hypertension was reversed acutely by injection of the angiotensin II antagonist, saralasin, into the brain ventricular system; intravenous saralasin injection elicited no observable response. Intraventricular injection of the alpha-2 adrenergic agonist, clonidine, did not lower blood pressure in experimental rats. We conclude that the experimental pre-eclampsia observed in these rats depends upon a central nervous system angiotensin II mechanism and not upon enhanced activation of the sympathetic nervous system.
25
Distribution of angiotensin II receptors in rat brain
Nancy E. Sirett, Ashleigh McLean, J. J. Bray et al. · Brain Research · 1977 · 303 citations
Max Berger, Denis Cavanagh · American Journal of Obstetrics and Gynecology · 1963 · 153 citations
Medicine, Neurology, Neuroscience +17